Showing 15,401 - 15,420 results of 48,330 for search '(( 12 we decrease ) OR ( 50 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 0.85s Refine Results
  1. 15401

    Image_1_A Label-Free Quantitative Proteomic Analysis of Mouse Neutrophil Extracellular Trap Formation Induced by Streptococcus suis or Phorbol Myristate Acetate (PMA).PDF by Xiaoping Wang (110673)

    Published 2018
    “…In the present study, we used a label-free quantitative proteomic analysis of mouse NET formation induced by S. suis or phorbol myristate acetate (PMA), a robust NET inducer. …”
  2. 15402

    PRISMA flow diagram of study selection. by Masoud Rahmati (16665456)

    Published 2025
    “…In contrast, distance vision impairment showed lower but still significant associations with IADL (OR = 1.19, 95% CI 1.05–1.34, <i>p</i> = 0.005) and a nonsignificant association with ADL (OR = 1.12, 95% CI 0.90–1.40, <i>p</i> = 0.30). Meta-regression analysis indicated that for every one-year increase in age, ADL performance decreased by an average of 0.0147 units (p < 0.001), while IADL performance declined at a slower rate of 0.0047 units/year (p = 0.031).…”
  3. 15403

    General characteristics of included studies. by Masoud Rahmati (16665456)

    Published 2025
    “…In contrast, distance vision impairment showed lower but still significant associations with IADL (OR = 1.19, 95% CI 1.05–1.34, <i>p</i> = 0.005) and a nonsignificant association with ADL (OR = 1.12, 95% CI 0.90–1.40, <i>p</i> = 0.30). Meta-regression analysis indicated that for every one-year increase in age, ADL performance decreased by an average of 0.0147 units (p < 0.001), while IADL performance declined at a slower rate of 0.0047 units/year (p = 0.031).…”
  4. 15404

    Characteristics of individual studies. by Masoud Rahmati (16665456)

    Published 2025
    “…In contrast, distance vision impairment showed lower but still significant associations with IADL (OR = 1.19, 95% CI 1.05–1.34, <i>p</i> = 0.005) and a nonsignificant association with ADL (OR = 1.12, 95% CI 0.90–1.40, <i>p</i> = 0.30). Meta-regression analysis indicated that for every one-year increase in age, ADL performance decreased by an average of 0.0147 units (p < 0.001), while IADL performance declined at a slower rate of 0.0047 units/year (p = 0.031).…”
  5. 15405

    Table 5_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  6. 15406

    Table 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  7. 15407

    Table 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  8. 15408

    Table 4_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.pdf by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  9. 15409

    Table 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.docx by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  10. 15410

    Image 2_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  11. 15411

    Image 3_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  12. 15412

    Image 1_Statin use during intensive care unit stay is associated with improved clinical outcomes in critically ill patients with sepsis: a cohort study.jpeg by Caifeng Li (3912883)

    Published 2025
    “…Additionally, statin use was associated with decreased ICU mortality (odds ratio [OR], 0.43; 95% CI, 0.37-0.49; p < 0.001) and reduced in-hospital mortality (OR, 0.50; 95% CI, 0.45-0.57; p < 0.001). …”
  13. 15413

    Table_1_Estrogen Protects Neurotransmission Transcriptome During Status Epilepticus.XLSX by Dumitru A. Iacobas (5423981)

    Published 2018
    “…<p>Women with epilepsy commonly have premature onset of menopause. The decrease in estrogen levels is associated with increased occurrence of neurodegenerative processes and cognitive decline. …”
  14. 15414

    <i>Rps6</i>-deficiency induces p53 and disrupts rRNA processing. by Sarah A. Comerford (3854917)

    Published 2023
    “…Original magnifications; a, d, e (x 125; scale bars, 50μ); b, c, f, g (x 250; scale bars, 25μ). …”
  15. 15415
  16. 15416
  17. 15417

    Presentation_1_Enhancement of Silymarin Anti-fibrotic Effects by Complexation With Hydroxypropyl (HPBCD) and Randomly Methylated (RAMEB) β-Cyclodextrins in a Mouse Model of Liver F... by Sami Gharbia (5623040)

    Published 2018
    “…Experimental fibrosis was induced by intraperitoneal injection with 2 ml/kg CCl<sub>4</sub> (20% v/v) twice a week, for 7 weeks. Mice were orally treated with 50 mg/kg of Sy-HPBCD, Sy-RAMEB and free silymarin. …”
  18. 15418

    Comparison of RPA2 dynamics in WT, <i>Cdk2</i><sup><i>T160A</i></sup>, <i>and Cdk2</i><sup><i>−/−</i></sup> spermatocytes. by Nathan Palmer (264897)

    Published 2020
    “…Data are presented as individual foci counts for WT (orange bars, N = 90 for early-pachytene and mid-pachytene stages), <i>Cdk2</i><sup><i>T160A</i></sup> (blue bars, N = 50 for early-pachytene and mid-pachytene stages), and <i>Cdk2</i><sup><i>−/−</i></sup> (gray bars, N = 50 for pachytene-like stage). …”
  19. 15419
  20. 15420

    Table_1_v1_Role of Female Research at the Asociacion Mexicana de Cirugia General Annual Meeting: A Retrospective Analysis From 2013 to 2019.docx by Lorelí Mejía-Fernández (12539746)

    Published 2022
    “…Females’ abstracts submitted have a 50 23.5% decreased chance of being selected for oral presentation (OR = 0.765, CI 95%, 0.639–0.917, 51 p = 0.003). …”